Shanghai Zhongxi Sunve Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYDROXYCHLOROQUINE SULFATE, with a corresponding US DMF Number 39296.
Remarkably, this DMF maintains an Active status since its submission on December 27, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 17, 2026, and payment made on December 05, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II